Literature DB >> 33625568

The constant search for the greater good: evolving from TURP to anatomic enucleation of the prostate is a safe bet.

Fernando Gómez-Sancha1.   

Abstract

PURPOSE: In a troubling moment in history with an ongoing world pandemic and the impending economic crises, there is today a plethora of commercially available options for the minimally invasive treatment of BPH. New industry-driven evaluation criteria of these treatments, the logical marketing hype, a short follow-up for many of them, make challenging to interpret the role they will finally adopt in the armamentarium to treat BPH.
METHOD: The author comments on recently published literature based in own experience and insight. RESULTS AND
CONCLUSIONS: In this situation, choosing to evolve from TURP to the next step of endoscopic treatment, the size-independent anatomic endoscopic enucleation of the prostate is a safe bet. It is now exceedingly feasible when the paradigm of AEEP has changed, due to better learning opportunities and technological and surgical technique modifications that have refined this procedure significantly since its inception.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  BPH; Minimally invasive; Prostate; Surgical treatment

Year:  2021        PMID: 33625568     DOI: 10.1007/s00345-021-03637-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  1 in total

1.  TURPxit or not: contemporary management options for benign prostatic obstruction.

Authors:  Thomas R W Herrmann; Vincent Misrai; Fernando Gómez Sancha; Thorsten Bach
Journal:  World J Urol       Date:  2021-07       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.